- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, April 9, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by HealthPayerIntelligence referenced a study published in the March 2019 issue of The American Journal of Managed Care® (AJMC®) titled “Health Insurance Literacy: Disparities by Race, Ethnicity, and Language Preference.” In the study, researchers found that compared with White enrollees in Connecticut qualified health plans, racial/ethnic minorities were disproportionately at risk for adverse health and financial consequences due to lower health insurance literacy.
A piece by FiercePharma spotlighted an article published on AJMC.com, the website of AJMC®. The article, “Cigna Dangles $500 to Persuade Patients to Switch Psoriasis Drugs,” reported that as the first quarter of 2021 ends, patients choosing to keep using secukinumab may be offered an inducement to switch to another biologic, ixekizumab. The article was also referenced by Becker’s Hospital Review.
An article by The Business Journals cited an article by AJMC®’s sister site The Center for Biosimilars®, titled “IQVIA: Biosimilars Could Save $100 Billion Over Next 5 Years.” The article covered a report from the IQVIA Institute for Human Data Science that predicts biosimilar sales of $80 billion over the next 5 years, as well as potential biosimilar-generated health care savings of more than $100 billion during that same period.
Mitigating Barriers to Cell and Gene Therapy Access
February 14th 2025Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, according to a white paper from the National Pharmaceutical Council.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
